[Antineuronal antibody in carcinomatous neuropathy]

Area of Science:

• Neurology
• Oncology
• Immunology

Background:

• Carcinomatous neuropathy is a rare neurological paraneoplastic syndrome associated with cancer.
• Small cell lung cancer (SCLC) is a common type of lung cancer that can be associated with paraneoplastic syndromes.

Observation:

• A 70-year-old woman presented with progressive paresthesias and weakness, diagnosed with SCLC.
• Neurological examination revealed sensory and motor deficits, with nerve biopsy showing axonal degeneration.
• Antineuronal antibodies targeting dorsal root ganglion neurons and Purkinje cells were detected in her serum.

Findings:

• The patient's antineuronal antibody titers decreased after cancer treatment.
• Western blot analysis identified a 38 kDa neuronal antigen recognized by the autoantibody.
• These findings suggest a potential autoimmune mechanism in carcinomatous neuropathy.

Implications:

• Antineuronal antibodies may play a role in the pathogenesis of carcinomatous neuropathy.
• Further research is needed to elucidate the precise mechanisms of cancer-associated neurological disorders.
• This case highlights the importance of identifying specific autoantibodies in paraneoplastic syndromes for diagnosis and management.